|
- Episode 153: New Non-Opioid Pain Medication: Journavx
She explores how it works, potential benefits for people with fibromyalgia, why it’s crucial to treat pain early, potential side effects and medication interactions related to Journavx, Tami’s optimism about ongoing research and the potential benefits for fibromyalgia patients, and more
- What to Know About Journavx, the Non-Opioid Pain Medication . . .
Journavx showed a “statistically significant superior reduction in pain” when compared to a placebo in two randomized trials of acute surgical pain, according to the FDA
- A New Pain Killer on the Market: The Good and the Not So Good . . .
While Journavx did not outperform the opioid combination of hydrocodone and acetaminophen (Vicodin), it provided effective pain relief without the associated risks of opioid use
- Journavx (suzetrigine) new non-opioid medication for acute pain
None of my physicians - pain doctor, neurologist, primary care - were familiar with it It is only approved for acute pain As I explained to my really wonderful PCP, those of us with chronic pain can also have acute pain I was preparing for a beach vacation, my first travel in a year, and it involved hours of airport time
- Beyond the Pain: A Systematic Narrative Review of the Latest . . .
This rigorous approach allowed for a robust analysis of the literature on fibromyalgia management In the course of our review, it became evident that a spectrum of treatment approaches holds significant promise in the management of fibromyalgia
- What Is Journavx? First Pain Medication Approved by FDA in . . .
Clinical trials demonstrated that the drug is effective in managing acute pain without the adverse effects commonly associated with opioid use Vertex Pharmaceuticals' development and approval of
- FDA Approves Novel Non-Opioid Treatment for Moderate to . . .
The FDA approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults
- Treatment of Fibromyalgia in the 21st Century - JAMA Network
Moreover, we believe that it is important to place expectations for fibromyalgia treatments into the perspective of treatments for other types of chronic pain
|
|
|